Quantum convoy covers 1,000 miles for cancer
Pharmaceutical specials manufacturer raises £5,000 for charity
The team signed up for the challenge after their colleague Tony Gallagher died of cancer in 2008.
Gallagher’s son, Scott, led the cycle convoy, which rode off from Land’s End in Cornwall and cycled up to 90 miles a day to cross the finishing line at John O’Groats in Caithness, Scotland a fortnight later.
‘It was a testing couple of weeks,’ said Quantum Pharmaceutical’s managing director Andy Scaife.
‘We remember Tony so fondly, and cycling a thousand miles will be nothing compared with the challenge he faced in fighting cancer. We just hope the money we raise will help other cancer sufferers as they battle with the disease.’
Quantum Pharmaceutical, based in Burnopfield, Co Durham, UK, is a pharmaceutical specials manufacturer licensed by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to supply pharmacies, chemists, dispensing doctors and hospitals with bespoke medicines.
You may also like
Cell & Gene Therapy
NGI Stockholm becomes first certified service provider for Epigenica's EpiFinder platform
Epigenica has signed an agreement with the National Genomics Infrastructure in Stockholm to offer end-to-end EpiFinder workflows for histone and DNA methylation profiling, establishing the first certified service provider in what the company describes as a growing global partner network
Manufacturing
etherna's mRNA and LNP platforms advance Dropshot Therapeutics' renal disease programme to clinical stage
etherna has announced that partner Dropshot Therapeutics has validated its platforms in preclinical renal disease research and will now progress to IND-enabling studies, with etherna providing GMP manufacturing support ahead of planned Phase I clinical trials in 2027